Findings With FT819 Demonstrate Promising, Accessible Approach … – Targeted Oncology
Targeted Oncology |
Findings With FT819 Demonstrate Promising, Accessible Approach …
Targeted Oncology Findings, presented at the 2018 AACR Annual Meeting, demonstrated that an off-the-shelf, dual-targeted chimeric antigen receptor (CAR) T-cell approach found positive results in preclinical specificity, functionality, and efficacy studies. FT819 Derives Renewable, Reproducible Process of CAR T-Cell Therapy |
